Project Apple, UCB

The Brief

Project Apple will create a research and development centre of excellence for the global pharmaceutical company UCB.

The brief places a heavy emphasis on re-use and recycle principles. Existing R&D buildings on the site will be refurbished and remodeled to provide state of the art laboratory facilities, with new link buildings, landscaping, footpaths and associated infrastructure unifying and connecting the whole campus. A new three storey timber collaboration hub, designed with Heatherwick Studio’s signature use of curved forms, will provide a focal point at the heart of the campus. The design of the hub includes a large atrium and events space overlooked by scalloped balconies on the two upper floors.


UCB Celltech




Lead Design:
Heatherwick Studio
Executive Architect: Veretec


80,000 ft²


  • Science


  • Health & Safety (CDM)

The Challenge

Sustainability goals influence every aspect of the design and delivery of the project as the completed campus is central to UCB’s commitment to achieve carbon neutrality for its operations by 2030.

The project is ongoing but we have already been able to contribute valuable input on challenging design safety issues associated with cleaning and maintenance access, particularly in relation to the new build central hub building.

The Outcome

As a result of our efforts and outstanding delivery during pre-construction, where we were appointed via Veretec, we were subsequently retained as the Client’s CDM advisor for the demolition and main works construction stage.

Once completed Windlesham will become one of UCB’s 3 global research and design hubs, providing the company with innovative space for the development and delivery of life changing solutions for those living with severe disease.

0 ft²
Size of central hub
Due for completion
"The 'world-class project team’ will redevelop and redefine the space at Windlesham to provide us with a state-of-the-art working environment".
Catherine Nikolaou
UCB Project Lead

Other Projects We’ve Completed Include

Gordon Murray

Royal College of Ophthalmologists